These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22001975)

  • 1. Anxiolytic-like activity of MGS0039, a selective group II mGlu receptor antagonist, is serotonin- and GABA-dependent.
    Stachowicz K; Wierońska J; Domin H; Chaki S; Pilc A
    Pharmacol Rep; 2011; 63(4):880-7. PubMed ID: 22001975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats.
    Yoshimizu T; Shimazaki T; Ito A; Chaki S
    Psychopharmacology (Berl); 2006 Jul; 186(4):587-93. PubMed ID: 16612616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity.
    Chaki S; Yoshikawa R; Hirota S; Shimazaki T; Maeda M; Kawashima N; Yoshimizu T; Yasuhara A; Sakagami K; Okuyama S; Nakanishi S; Nakazato A
    Neuropharmacology; 2004 Mar; 46(4):457-67. PubMed ID: 14975669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist.
    Karasawa J; Shimazaki T; Kawashima N; Chaki S
    Brain Res; 2005 Apr; 1042(1):92-8. PubMed ID: 15823257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic-like activity of MGS0039, a potent group II metabotropic glutamate receptor antagonist, in a marble-burying behavior test.
    Shimazaki T; Iijima M; Chaki S
    Eur J Pharmacol; 2004 Oct; 501(1-3):121-5. PubMed ID: 15464070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.
    Pałucha-Poniewiera A; Wierońska JM; Brański P; Stachowicz K; Chaki S; Pilc A
    Psychopharmacology (Berl); 2010 Dec; 212(4):523-35. PubMed ID: 20703449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
    Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
    Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell.
    Karasawa J; Yoshimizu T; Chaki S
    Neurosci Lett; 2006 Jan; 393(2-3):127-30. PubMed ID: 16233956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
    Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
    Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodrugs of 3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): a potent and orally active group II mGluR antagonist with antidepressant-like potential.
    Yasuhara A; Nakamura M; Sakagami K; Shimazaki T; Yoshikawa R; Chaki S; Ohta H; Nakazato A
    Bioorg Med Chem; 2006 Jun; 14(12):4193-207. PubMed ID: 16487713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems.
    Wierońska JM; Stachowicz K; Pałucha-Poniewiera A; Acher F; Brański P; Pilc A
    Neuropharmacology; 2010 Dec; 59(7-8):627-34. PubMed ID: 20713068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors.
    Kawashima N; Karasawa J; Shimazaki T; Chaki S; Okuyama S; Yasuhara A; Nakazato A
    Neurosci Lett; 2005 Apr; 378(3):131-4. PubMed ID: 15781145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.
    Stachowicz K; Gołembiowska K; Sowa M; Nowak G; Chojnacka-Wójcik E; Pilc A
    Neuropharmacology; 2007 Nov; 53(6):741-8. PubMed ID: 17870136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
    Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor.
    Sławińska A; Wierońska JM; Stachowicz K; Pałucha-Poniewiera A; Uberti MA; Bacolod MA; Doller D; Pilc A
    Neuropharmacology; 2013 Mar; 66():225-35. PubMed ID: 22634361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
    Koike H; Iijima M; Chaki S
    Neuropharmacology; 2011 Dec; 61(8):1419-23. PubMed ID: 21903115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
    Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze.
    Ferris P; Seward E; Dawson GR
    J Psychopharmacol; 2001 Jun; 15(2):76-82. PubMed ID: 11448091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam.
    Tizzano JP; Griffey KI; Schoepp DD
    Pharmacol Biochem Behav; 2002 Sep; 73(2):367-74. PubMed ID: 12117591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors.
    Wesołowska A
    Eur J Pharmacol; 2008 Feb; 580(3):355-60. PubMed ID: 18096153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.